Optimization of RNA concentration for genome editing by CRISPR in rabbit zygotes by Fonseca Baldís, N. et al.
 Proceedings of the 30th Annual Meeting of the Brazilian Embryo Technology Society (SBTE); Foz do Iguaçu, PR, 
Brazil, August 25th to 27th, 2016, and 32nd Meeting of the European Embryo Transfer Association (AETE); 
Barcelona, Spain, September 9th and 10th, 2016. Abstracts. 
 
Anim. Reprod., v.13, n.3, p.683, Jul./Sept. 2016 683 
A309E  Cloning, Transgenesis and Stem Cells  
 
Optimization of RNA concentration for genome editing by CRISPR in rabbit zygotes 
 
N. Fonseca Balvís1,*, P.L. Lorenzo2, A. Gutiérrez-Adán1, P.G. Rebollar3, M. Avilés4, P. Bermejo-Álvarez1 
 
1Dpto Reproducción Animal, INIA, Madrid, Madrid, Spain; 2Dpto Fisiología Animal, Universidad Complutense de Madrid, 
Madrid, Madrid, Spain; 3Dpto Producción Animal, Universidad Politécnica de Madrid, Madrid, Madrid, Spain; 4Dpto Biología 
Celular e Histología, Universidad de Murcia, Murcia, Murcia, Spain. 
 
 
Keywords: CRISPR, rabbit, zona pellucida. 
 
Site-specific genetic modification aiming to delete (knock-out) a gene provides an unequivocal answer to elucidate 
the function of such particular gene in the whole organism. Site-specific genetic modification has been achieved by 
homologous recombination, generally in embryonic stem cells, which has made the mouse the most widely used 
mammalian model. However, the mouse model is not appropriate to study some biological functions or to 
recapitulate some human diseases. As an example, ZP4, one of the four proteins of the zona pellucida in humans and 
rabbits, is not present in mice, so its function remains elusive due to the lack of a knock-out model. The use of the 
newly developed site-specific endonucleases, such as CRISPR, allows site-specific genetic modification in zygotes, 
being a suitable technique for genetic modification in domestic mammalian species. The aim of this experiment has 
been to determine the optimal concentration of the two components of the CRISPR system (Cas9 mRNA and 
gdRNA) for genome editing following microinjection of rabbit zygotes. Capped polyadenylated Cas9 mRNA was 
produced by in vitro transcription from BstBI digested pMJ920 plasmid. A gdRNA was designed against the first 
exon of rabbit ZP4 gene, cloned into the plasmid px330, amplified by PCR adding T7 promoter and in vitro 
transcribed. Rabbit zygotes were obtained from the oviduct 14 hours after mating. Immediately after collection, 
zygotes were microinjected into the ooplasm with approximately 10 picoliters of three different combinations of 
Cas9 capped polyadenylated mRNA and gdRNA: 1) 300 ng/µl Cas9 and 150 ng/µl of gdRNA (300:150), 2) 150 
ng/µl Cas9 and 50 ng/µl gdRNA (150:50) and 3) 100 ng/µl Cas9 and 25 ng/µl gdRNA (100:25). Following 
microinjection, embryos were cultured in TCM199 supplemented with 5% FCS at 38.5ºC in a 5% CO2, 5% O2 and 
90% N2 water saturated atmosphere. CRISPR components did not affect preimplantation development, as all 
embryos surviving microinjection (~90%) developed to the blastocyst stage. At the blastocyst stage, the zona pellucida 
was removed and blastocysts were individually stored at -20 ºC. Blastocysts were digested in 8 µl of a 100 µg/ml 
proteinase K buffered solution and 2 µl of the lysate were used to amplify the genomic sequence including the 
CRISPR target site. PCR products were purified and sequenced to determine genome edition around the target site. 
All combinations were similarly effective in generating insertion/deletions around the target site: in the groups 
300:150 and 150:50 all blastocysts analysed (6/6 in both groups) were edited, whereas in the group 100:25 only one 
blastocyst out of six was not edited. In conclusion, CRISPR system constitutes an effective means for genome 
editing in rabbit zygotes and the ooplasm microinjection of 100 ng/µl capped polyadenylated Cas9 mRNA and 
25 ng/µl gdRNA achieves high genome editing efficiencies. 
 
This study is supported by the projects AGL2014-58739-R and RYC-2012-10193 (to PBA), AGL2012-40180-C03-
02 (to MA), AGL2011-23822 (to PGR and PL) and AGL2012-39652-C02-01 (to AGA). NFB is supported by a FPI 
grant.
